ReviewBioscience reports2026
Quorum sensing in streptococci and its peptide-mediated modulation.
Review in Bioscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Quorum sensing (QS) is a density-dependent communication process that enables bacteria to coordinate group behaviors, including competence, biofilm formation, bacteriocin production, and virulence. Early observations of genetic transformation in Streptococcus pneumoniae and density-dependent bioluminescence in marine bacteria laid the foundation for the eventual unification of these phenomena under the QS framework. In streptococci, QS is mediated primarily by secreted peptide pheromones that are processed, exported, and sensed through either membrane-associated two-component signal transduction systems or intracellular RRNPP-family regulators. These signaling pathways control tightly regulated and often transient physiological states, most notably competence, through interconnected regulatory circuits such as ComABCDE and ComRS. Increasing evidence indicates that, in some streptococci, these systems do not operate in isolation but instead form integrated and, in some cases, noncanonical networks that respond to environmental and metabolic cues. The chemical accessibility of peptide signals has enabled detailed structure-activity relationship studies, revealing key determinants of receptor activation and specificity. In particular, systematic modification of competence-stimulating peptides (CSPs) and sigX-inducing peptides (XIPs) has led to the identification of residues critical for activity and enabled the development of peptide analogs that act as agonists or competitive antagonists of QS pathways. These studies have demonstrated that synthetic peptides can modulate QS-regulated phenotypes, including competence, and in some cases attenuate infection in vivo. Collectively, these advances establish streptococcal QS as a chemically tractable system and highlight peptide-based modulation as a strategy for probing and influencing bacterial communication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.